Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 42Genitourinary 12Gastrointestinal 9Gynecologic 7Other hematologic neoplasm 5Head & Neck 5Thoracic 3Sarcoma 3Myeloid 3Lymphoid 3Endocrine 2Tumor-Agnostic 1Plasma cell 1Other solid neoplasm 1Other neoplasm 1Other 1Dermatologic 1CNS 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1

Interventions

Cisplatin 60Carboplatin 55Cyclophosphamide 47Pemetrexed 45Irinotecan 33pembrolizumab 32Paclitaxel 29Etoposide 29Gemcitabine 28Nivolumab 24Bevacizumab 24Interviews as Topic 23Vincristine 22Capecitabine 22Topotecan 20Filgrastim 20Early Intervention, Educational 20fludarabine 19Oxaliplatin 19Docetaxel 19Specimen Handling 18Drug Therapy 18Temozolomide 17Sorafenib 17Leucovorin 17Everolimus 17Educational Status 17Radiotherapy 16Methods 16Fluorouracil 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × High-Energy Shock Waves × Other solid neoplasm × Clear all
NCT00390000 2019-04-08

Vatalanib and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors

Mayo Clinic

Phase 1 Completed
29 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡